JP2024503235A5 - - Google Patents
Info
- Publication number
- JP2024503235A5 JP2024503235A5 JP2023537491A JP2023537491A JP2024503235A5 JP 2024503235 A5 JP2024503235 A5 JP 2024503235A5 JP 2023537491 A JP2023537491 A JP 2023537491A JP 2023537491 A JP2023537491 A JP 2023537491A JP 2024503235 A5 JP2024503235 A5 JP 2024503235A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- ppm
- crystal according
- values
- cukα radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026067895A JP2026123057A (ja) | 2020-12-24 | 2026-04-16 | Ｃｄｋ２阻害剤の固体形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130530P | 2020-12-24 | 2020-12-24 | |
| US63/130,530 | 2020-12-24 | ||
| PCT/IB2021/062082 WO2022137106A1 (en) | 2020-12-24 | 2021-12-21 | Solid forms of a cdk2 inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026067895A Division JP2026123057A (ja) | 2020-12-24 | 2026-04-16 | Ｃｄｋ２阻害剤の固体形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503235A JP2024503235A (ja) | 2024-01-25 |
| JP2024503235A5 true JP2024503235A5 (enExample) | 2024-11-28 |
Family
ID=79283019
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537491A Pending JP2024503235A (ja) | 2020-12-24 | 2021-12-21 | Ｃｄｋ２阻害剤の固体形態 |
| JP2026067895A Pending JP2026123057A (ja) | 2020-12-24 | 2026-04-16 | Ｃｄｋ２阻害剤の固体形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026067895A Pending JP2026123057A (ja) | 2020-12-24 | 2026-04-16 | Ｃｄｋ２阻害剤の固体形態 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240076287A1 (enExample) |
| EP (1) | EP4267563A1 (enExample) |
| JP (2) | JP2024503235A (enExample) |
| KR (1) | KR20230122100A (enExample) |
| CN (1) | CN116723837B (enExample) |
| AU (1) | AU2021404974B2 (enExample) |
| CA (1) | CA3206153A1 (enExample) |
| MX (1) | MX2023007699A (enExample) |
| TW (1) | TWI823213B (enExample) |
| WO (1) | WO2022137106A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3217792A1 (en) | 2021-05-07 | 2022-11-10 | Kymera Therapeutics, Inc | Cdk2 degraders and uses thereof |
| US20250127759A1 (en) * | 2021-12-02 | 2025-04-24 | Pfizer Inc. | Methods and dosing regimens comprising a cdk2 inhibitor for the treatment of cancer |
| CN118679150A (zh) * | 2022-01-27 | 2024-09-20 | 益方生物科技(上海)股份有限公司 | Cdk2抑制剂及其制备方法和用途 |
| WO2024046443A1 (en) * | 2022-09-01 | 2024-03-07 | Nutshell Biotech (Shanghai) Co., Ltd. | Macrocyclic compounds as selective cdk inhibitors |
| WO2025191482A1 (en) | 2024-03-15 | 2025-09-18 | Pfizer Inc. | Synthesis of (1h-pyrazol-5-yl)cyclopentyl carbamate compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| CA3128155C (en) * | 2019-01-31 | 2023-09-19 | Pfizer Inc. | 3-carbonylamino-5-cyclopentyl-1h-pyrazole compounds having inhibitory activity on cdk2 |
-
2021
- 2021-12-21 MX MX2023007699A patent/MX2023007699A/es unknown
- 2021-12-21 WO PCT/IB2021/062082 patent/WO2022137106A1/en not_active Ceased
- 2021-12-21 AU AU2021404974A patent/AU2021404974B2/en active Active
- 2021-12-21 KR KR1020237024476A patent/KR20230122100A/ko active Pending
- 2021-12-21 CN CN202180086069.9A patent/CN116723837B/zh active Active
- 2021-12-21 EP EP21839682.8A patent/EP4267563A1/en active Pending
- 2021-12-21 CA CA3206153A patent/CA3206153A1/en active Pending
- 2021-12-21 US US18/268,959 patent/US20240076287A1/en active Pending
- 2021-12-21 JP JP2023537491A patent/JP2024503235A/ja active Pending
- 2021-12-23 TW TW110148386A patent/TWI823213B/zh active
-
2026
- 2026-04-16 JP JP2026067895A patent/JP2026123057A/ja active Pending